Helius Medical Technologies, Inc. to Present at the 2024 ThinkEquity Conference
Helius Medical Technologies, a neurotech company focused on innovative treatments for balance and gait deficits, has announced its participation in the 2024 ThinkEquity Conference. The event, scheduled for October 30, 2024, will take place at the Mandarin Oriental Hotel in New York.
Helius management will be presenting at 4:30pm ET and conducting one-on-one investor meetings throughout the day. The ThinkEquity Conference is a platform that brings together institutional investors, corporate clients, and industry professionals to showcase groundbreaking innovations and financial strategies.
Interested investors can register to attend the conference and schedule meetings with Helius representatives. This event provides an opportunity for Helius to highlight its novel therapeutic neuromodulation approach and engage with potential investors.
Helius Medical Technologies, un'azienda di neurotecnologie focalizzata su trattamenti innovativi per i deficit di equilibrio e deambulazione, ha annunciato la sua partecipazione al ThinkEquity Conference 2024. L'evento, previsto per il 30 ottobre 2024, si terrà presso il Mandarin Oriental Hotel di New York.
La direzione di Helius sarà presenta alle 16:30 ET e condurrà incontri individuali con gli investitori durante tutto il giorno. La ThinkEquity Conference è una piattaforma che riunisce investitori istituzionali, clienti aziendali e professionisti del settore per mostrare innovazioni groundbreaking e strategie finanziarie.
Gli investitori interessati possono registrarsi per partecipare alla conferenza e pianificare incontri con i rappresentanti di Helius. Questo evento offre l'opportunità a Helius di mettere in evidenza il suo approccio innovativo alla neuromodulazione terapeutica e interagire con potenziali investitori.
Helius Medical Technologies, una empresa de neurotecnología centrada en tratamientos innovadores para déficits de equilibrio y marcha, ha anunciado su participación en la Conferencia ThinkEquity 2024. El evento, programado para el 30 de octubre de 2024, tendrá lugar en el Hotel Mandarin Oriental de Nueva York.
La dirección de Helius estará presentando a las 4:30 p.m. ET y llevará a cabo reuniones uno a uno con inversores durante todo el día. La Conferencia ThinkEquity es una plataforma que reúne a inversores institucionales, clientes corporativos y profesionales de la industria para mostrar innovaciones revolucionarias y estrategias financieras.
Los inversores interesados pueden registrarse para asistir a la conferencia y programar reuniones con los representantes de Helius. Este evento ofrece una oportunidad para que Helius resalte su novedoso enfoque de neuromodulación terapéutica y se relacione con posibles inversores.
헬리우스 메디컬 테크놀로지스, 균형 및 보행 결핍에 대한 혁신적인 치료법에 중점을 둔 신경 기술 회사가 2024 씽크이쿼티 콘퍼런스에 참여한다고 발표했습니다. 이 행사는 2024년 10월 30일에 뉴욕 만다린 오리엔탈 호텔에서 개최됩니다.
헬리우스 경영진은 오후 4시 30분 ET에 발표하며 하루 종일 일대일 투자자 회의를 진행할 예정입니다. 씽크이쿼티 콘퍼런스는 기관 투자자, 기업 고객 및 업계 전문가들이 모여 혁신적인 아이디어와 재무 전략을 선보이는 플랫폼입니다.
관심 있는 투자자는 컨퍼런스에 참석하기 위해 등록하고 헬리우스 대표와의 회의를 일정에 맞출 수 있습니다. 이 행사는 헬리우스가 새로운 치료적 신경조절 접근 방식을 강조하고 잠재적 투자자와의 관계를 발전시킬 수 있는 기회를 제공합니다.
Helius Medical Technologies, une entreprise de neurotechnologie axée sur des traitements innovants pour les déficits d'équilibre et de marche, a annoncé sa participation à la Conférence ThinkEquity 2024. L'événement, prévu pour le 30 octobre 2024, se tiendra à l'Hôtel Mandarin Oriental de New York.
La direction de Helius sera présente à 16h30 ET et mènera des réunions individuelles avec des investisseurs tout au long de la journée. La Conférence ThinkEquity est une plateforme qui rassemble des investisseurs institutionnels, des clients d'entreprise et des professionnels de l'industrie pour présenter des innovations révolutionnaires et des stratégies financières.
Les investisseurs intéressés peuvent s'inscrire pour assister à la conférence et planifier des réunions avec les représentants de Helius. Cet événement offre à Helius l'opportunité de mettre en avant son approche innovante de la neuromodulation thérapeutique et de nouer des relations avec des investisseurs potentiels.
Helius Medical Technologies, ein Neurotech-Unternehmen, das sich auf innovative Behandlungen von Gleichgewichts- und Gangdefiziten konzentriert, hat seine Teilnahme an der 2024 ThinkEquity-Konferenz bekannt gegeben. Die Veranstaltung, die für den 30. Oktober 2024 geplant ist, findet im Mandarin Oriental Hotel in New York statt.
Das Management von Helius wird um 16:30 Uhr ET præsentieren und den ganzen Tag über Einzelgespräche mit Investoren führen. Die ThinkEquity-Konferenz ist eine Plattform, die institutionelle Investoren, Unternehmenskunden und Branchenprofis zusammenbringt, um bahnbrechende Innovationen und Finanzstrategien zu präsentieren.
Interessierte Investoren können sich registrieren, um an der Konferenz teilzunehmen und Meetings mit Helius-Vertretern zu vereinbaren. Diese Veranstaltung bietet Helius die Gelegenheit, ihren neuartigen therapeutischen Neuromodulationsansatz hervorzuheben und mit potenziellen Investoren in Kontakt zu treten.
- None.
- None.
NEWTOWN, Pa., Oct. 18, 2024 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (“Helius” or the “Company”) [Nasdaq: HSDT], a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today announced that it plans to participate in The ThinkEquity Conference on October 30, 2024, at the Mandarin Oriental Hotel in New York. The ThinkEquity Conference gathers institutional investors, corporate clients, and other industry professionals to highlight groundbreaking innovations and financial strategies.
Management will be presenting at 4:30pm ET on October 30th and holding one-on-one investor meetings throughout the day. Interested investors can register to attend and schedule on-on-one meetings here.
About ThinkEquity
ThinkEquity is a boutique investment bank founded by professionals who have collaborated for over a decade, collectively financing over
About Helius Medical Technologies, Inc.
Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using orally applied technology platform that amplifies the brain’s ability to engage physiologic compensatory mechanisms and promote neuroplasticity, improving the lives of people dealing with neurologic diseases. The Company’s first commercial product is the Portable Neuromodulation Stimulator. For more information about the PoNS® or Helius Medical Technologies, visit www.heliusmedical.com.
Investor Relations Contact
Philip Trip Taylor
Gilmartin Group
investorrelations@heliusmedical.com
FAQ
When and where is Helius Medical Technologies (HSDT) presenting at the 2024 ThinkEquity Conference?
What opportunities does the 2024 ThinkEquity Conference offer for Helius Medical Technologies (HSDT)?
How can investors participate in Helius Medical Technologies' (HSDT) presentation at the 2024 ThinkEquity Conference?
What is the focus of Helius Medical Technologies (HSDT) as presented in the 2024 ThinkEquity Conference announcement?
